A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells
Tingting Gao,Xiyuan Zhao,Jie Hao,Yao Tian,Huike Ma,Wenjing Liu,Bin An,Faguo Sun,Shasha Liu,Baojie Guo,Shuaishuai Niu,Zhongwen Li,Chenxin Wang,Yukai Wang,Guihai Feng,Liu Wang,Wei Li,Jun Wu,Meijin Guo,Qi Zhou,Qi Gu
DOI: https://doi.org/10.1016/j.mtbio.2023.100662
IF: 8.2
2023-05-07
Materials Today Bio
Abstract:Mesenchymal stromal cells (MSCs) derived from human embryonic stem cells (hESCs) are a desirable cell source for cell therapy owing to their capacity to be produced stably and homogeneously in large quantities. However, a scalable culture system for hPSC-derived MSCs is urgently needed to meet the cell quantity and quality requirements of practical clinical applications. In this study, we developed a new microcarrier with hyaluronic acid (HA) as the core material, which allowed scalable serum-free suspension culture of hESC-derived MSCs (IMRCs). We used optimal microcarriers with a coating collagen concentration of 100 μg/mL or concave-structured surface (cHAMCs) for IMRC amplification in a stirred bioreactor, expanding IMRCs within six days with the highest yield of over one million cells per millilitre. In addition, the harvested cells exhibited high viability, immunomodulatory and regenerative therapeutic promise comparable to monolayer cultured MSCs while exhibiting more increased secretion of extracellular matrix (ECM), particularly collagen-related proteins. In summary, we have established a scalable culture system for hESC-MSCs, providing novel approaches for future cell therapies.
engineering, biomedical,materials science, biomaterials